UPMC Children's Hospital of Pittsburgh

Little Giraffe Foundation Names 2023 NICU Support Grant Recipients

Retrieved on: 
Wednesday, November 1, 2023

CHICAGO, Nov. 1, 2023 /PRNewswire-PRWeb/ -- Little Giraffe Foundation, a registered 501(c)(3) organization dedicated to funding neonatal research and supporting families and premature babies in the NICU, announced the 15 recipients of the foundation's 2023 NICU Support Grants. Since 2011, the Little Giraffe Foundation has delivered hospital bags to more than 26,000 families, provided $139,000 toward 148 separate NICU support grants, and provided more than $300,000 in medical grants to 34 different research initiatives. From direct family contact through the gift bags to the upleveling of research and care the support and medical grants provide—every dollar that goes to the Little Giraffe Foundation goes to ensuring the immediate and future care of NICU patients.

Key Points: 
  • CHICAGO, Nov. 1, 2023 /PRNewswire-PRWeb/ -- Little Giraffe Foundation , a registered 501(c)(3) organization dedicated to funding neonatal research and supporting families and premature babies in the NICU, announced the 15 recipients of the foundation's 2023 NICU Support Grants.
  • Since 2011, the Little Giraffe Foundation has delivered hospital bags to more than 26,000 families, provided $139,000 toward 148 separate NICU support grants, and provided more than $300,000 in medical grants to 34 different research initiatives.
  • Thanks to the incredible generosity of our donors, we've been able to allocate 15 grants towards vital NICU programs," said Amanda Santoro, the co-founder and president of the Little Giraffe Foundation.
  • This year's Little Giraffe Foundation's NICU Support Grant recipients are as follows:
    UPMC Carlisle, Carlisle, Pennsylvania — to receive $1,000 for food for mothers of breast-feeding infants, food for the immediate families of NICU infants, gas vouchers for rural families, and direct transportation vouchers for those who live in Carlisle.

Invitae to Present Data at the National Society of Genetic Counselors 42nd Annual Conference That Supports Advancements in Medical Genomics

Retrieved on: 
Tuesday, October 10, 2023

SAN FRANCISCO, Oct. 10, 2023 /PRNewswire/ -- Researchers from Invitae (NYSE: NVTA), a leading medical genetics company, are showcasing their work next week at the National Society of Genetic Counselors (NSGC) 42nd Annual Conference in Chicago that highlights the importance of genetics-informed patient care. In addition to its research presentations, the company will present the Heart of Genetic Counseling Award which recognizes excellence in the field of genetic counseling.

Key Points: 
  • In addition to its research presentations, the company will present the Heart of Genetic Counseling Award which recognizes excellence in the field of genetic counseling.
  • "The NSGC Annual Conference is a great opportunity for Invitae researchers to share cutting-edge scientific advancements with genetic counselors who play an integral role in genetics-informed patient care," said Robert Nussbaum, M.D., chief medical officer at Invitae.
  • Invitae joins NSGC in presenting the Heart of Genetic Counseling Award – honoring excellence in genetic counseling and patient care as recognized by patients.
  • To learn more about Invitae's presence at the NSGC 42nd Annual Conference or the Heart of Genetic Counseling Award, visit our website .

St. Joseph's Children's Hospital Implants 250th Pulmonary Valve Without Open-Heart Surgery

Retrieved on: 
Tuesday, October 3, 2023

TAMPA, Fla., Oct. 3, 2023 /PRNewswire/ -- The Patel Children's Heart Institute at St. Joseph's Children's Hospital achieved a milestone recently, implanting its 250th congenital transcatheter heart valve.

Key Points: 
  • TAMPA, Fla., Oct. 3, 2023 /PRNewswire/ -- The Patel Children's Heart Institute at St. Joseph's Children's Hospital achieved a milestone recently, implanting its 250th congenital transcatheter heart valve.
  • "Most importantly, this means that we allowed 250 patients in need of pulmonary or tricuspid valve replacement to avoid open-heart surgery."
  • He was born with pulmonary stenosis, a heart defect in which the pulmonary valve is narrowed and opens poorly.
  • Pino underwent open-heart surgery when he was 9 years old to open up the narrowed valve, trading blockage for leakage.

UPMC Children's Hospital Foundation Receives Record $8 Million Gift

Retrieved on: 
Tuesday, October 3, 2023

PITTSBURGH , Oct. 3, 2023 /PRNewswire/ -- UPMC Children's Hospital Foundation has received its largest gift to date from an individual with a $8 million bequest from the estate of Mr. David V. Duchini to support UPMC Children's Hospital of Pittsburgh .

Key Points: 
  • PITTSBURGH , Oct. 3, 2023 /PRNewswire/ -- UPMC Children's Hospital Foundation has received its largest gift to date from an individual with a $8 million bequest from the estate of Mr. David V. Duchini to support UPMC Children's Hospital of Pittsburgh .
  • Duchini personally selected these recipients with the guidance of his friends, estate trustee, and UBS financial advisor, Helene Naftali, who recommended the gift to the Foundation.
  • "We're thrilled and honored to receive such a generous gift from the Duchini estate," said Rachel Petrucelli, president of UPMC Children's Hospital Foundation.
  • For more information on UPMC Children's Hospital Foundation, or to donate through estate planning, visit www.givetochildrens.org .

20 Facilities Ranked as the 2023 Most Beautiful Hospitals in the U.S.

Retrieved on: 
Wednesday, August 2, 2023

ATLANTA, GA., Aug. 02, 2023 (GLOBE NEWSWIRE) -- National staffing firm Soliant today named the 2023 Top 20 Most Beautiful Hospitals in the U.S.

Key Points: 
  • ATLANTA, GA., Aug. 02, 2023 (GLOBE NEWSWIRE) -- National staffing firm Soliant today named the 2023 Top 20 Most Beautiful Hospitals in the U.S.
  • The annual contest aims to recognize hospitals across the country for their facility design, comforting staff and patient experience through a nomination and voting process.
  • The top hospital, Providence Hospital, will receive a $5,000 donation to its foundation.
  • To learn more about Soliant’s Top 20 Most Beautiful Hospitals in the U.S. contest, please visit soliant.com/most-beautiful-hospital-contest .

UPMC Children's Hospital Foundation Announces Board Leadership Transition

Retrieved on: 
Thursday, July 20, 2023

PITTSBURGH, July 20, 2023 /PRNewswire/ -- The UPMC Children's Hospital Foundation Board of Trustees have announced new leadership.

Key Points: 
  • PITTSBURGH, July 20, 2023 /PRNewswire/ -- The UPMC Children's Hospital Foundation Board of Trustees have announced new leadership.
  • Vanessa Morehouse, who has been a board member for more than 11 years, will now assume the role of Foundation Chair.
  • Morehouse will not only serve as the Foundation Chair, but will continue her service on the Foundation's Executive, Finance and Investment, Nominating and Marketing Committees, and as a member of the Board of Trustees at UPMC Children's Hospital of Pittsburgh.
  • For more information on UPMC Children's Hospital Foundation, visit www.givetochildrens.org .

CareDx Presents Latest Advancements at 12th Congress of the International Pediatric Transplant Association

Retrieved on: 
Thursday, March 23, 2023

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced its gold-level sponsorship and participation at the 12th Congress of the International Pediatric Transplant Association (IPTA) taking place March 25-28, 2023, in Austin, Texas.

Key Points: 
  • CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced its gold-level sponsorship and participation at the 12th Congress of the International Pediatric Transplant Association (IPTA) taking place March 25-28, 2023, in Austin, Texas.
  • “CareDx is 100% committed to driving transplant innovation and this is especially important for pediatric patients who require decades of graft function.
  • “We are very proud to once again be one of the lead sponsors for the 12th Congress of the IPTA – an organization at the forefront of advancing science and technology for pediatric patients.”
    CareDx will host a symposium highlighting the company’s latest developments in pediatric heart and kidney transplant patient care.
  • The symposium, “Paradigm Shifts in Pediatric Surveillance Testing: AlloSure and AlloMap in Action” will be held on Sunday, March 26, from 12:30 – 1:30pm CDT.

The American Board of Oral and Maxillofacial Surgery Names New Leaders

Retrieved on: 
Tuesday, October 18, 2022

NEW ORLEANS, Oct. 18, 2022 /PRNewswire/ -- The American Board of Oral and Maxillofacial Surgery (ABOMS) named new leaders during their September 2022 Annual Meeting in New Orleans. The new president Bernard J. Costello DMD, MD, FACS is an accomplished oral and maxillofacial surgeon, professor, and leader in the field; he will serve a one-year term as President of ABOMS.

Key Points: 
  • President Bernard J. Costello DMD, MD, FACS and board member Deepak Krishnan, DDS, FACS will serve as leaders of the U.S. oral and maxillofacial certifying board.
  • NEW ORLEANS, Oct. 18, 2022 /PRNewswire/ -- The American Board of Oral and Maxillofacial Surgery (ABOMS) named new leaders during their September 2022 Annual Meeting in New Orleans.
  • "For me, the chance to work with the Board of Directors of the American Board of Oral and Maxillofacial Surgery as president is a career pinnacle.
  • About the American Board of Oral and Maxillofacial Surgery:The American Board of Oral and Maxillofacial Surgery (ABOMS) is the only American Dental Association (ADA)-recognized certifying board for the specialty of oral and maxillofacial surgery in the United States.

Cue Health Applies with FDA for Emergency Use Authorization of its Cue Flu + COVID-19 Molecular Test

Retrieved on: 
Tuesday, October 4, 2022

SAN DIEGO, Oct. 4, 2022 /PRNewswire/ -- Cue Health ("Cue") (Nasdaq: HLTH), a healthcare technology company that puts diagnostic information at the center of care, today announced that on September 30, 2022, it submitted an application with the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) for its Cue® Flu + COVID-19 Molecular Test for at-home and point-of-care (POC) use.

Key Points: 
  • The new Cue Flu + COVID-19 Molecular Test can simultaneously detect and differentiate between influenza and COVID-19 in approximately 25 minutes, with results delivered digitally to the Cue Health App on the user's mobile device.
  • The Cue Flu + COVID-19 Molecular Test Cartridge uses a lower nasal swab sample and runs on the Cue Reader, which communicates test results digitally to the Cue Health App on a mobile device.
  • Currently, Cue's standalone molecular tests for both flu and COVID-19 are under de novo review with the FDA for full clearance.
  • Cue Health's first-of-its-kind COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without a prescription and physician supervision.

Cue Health Makes De Novo Submission to FDA for Full Clearance of its Cue® Flu Molecular Test

Retrieved on: 
Thursday, September 1, 2022

FDA clearance of Cue's test would provide the public, for the first time, an at-home and POC molecular flu test that has been fully reviewed by the FDA for safety and effectiveness.

Key Points: 
  • FDA clearance of Cue's test would provide the public, for the first time, an at-home and POC molecular flu test that has been fully reviewed by the FDA for safety and effectiveness.
  • Clinical study results with the Cue Flu Molecular Test were favorable, demonstrating 99% accuracy1compared to FDA cleared molecular (PCR) laboratory tests for influenza A&B.
  • The Cue Flu Molecular Test cartridge uses a lower nasal swab and is compatible with the Cue Reader, which communicates test results digitally via Bluetooth to a mobile device in approximately 25 minutes.
  • "This FDA submission for our Cue Flu Molecular Test is another important milestone on Cue's path to pioneer a new approach to diagnostics in homes, enterprises, and healthcare settings," said Ayub Khattak, Chairman and CEO of Cue Health.